Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micafungin vs Amphotericin B for Invasive Fungal Infection in Preterm Neonates
NCT06413056Phase 4Completed
- Sponsor
- Ain Shams University
- Start
- Oct 2022
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of micafungin in invasive fungal infection (IFI) (2 arms), sponsored by Ain Shams University. Primary endpoint: Resolution of fungal infection at 14 days. Started Oct 2022; status: completed.
02
Drugs
micafungin
03
Conditions
invasive fungal infection (IFI)
Beyond the preview
Go deeper on NCT06413056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06413056.